000 | 01269 a2200313 4500 | ||
---|---|---|---|
005 | 20250516215423.0 | ||
264 | 0 | _c20150526 | |
008 | 201505s 0 0 eng d | ||
022 | _a1365-2753 | ||
024 | 7 |
_a10.1111/jep.12184 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBaldo, Paolo | |
245 | 0 | 0 |
_aPharmacovigilance in oncology: evaluation of current practice and future perspectives. _h[electronic resource] |
260 |
_bJournal of evaluation in clinical practice _cOct 2014 |
||
300 |
_a559-69 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAdverse Drug Reaction Reporting Systems _xorganization & administration |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aBiosimilar Pharmaceuticals _xadverse effects |
650 | 0 | 4 | _aCommunication |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInformation Systems _xorganization & administration |
650 | 0 | 4 | _aPatient Education as Topic |
650 | 0 | 4 | _aPharmacovigilance |
650 | 0 | 4 |
_aPrecision Medicine _xadverse effects |
700 | 1 | _aDe Paoli, Paolo | |
773 | 0 |
_tJournal of evaluation in clinical practice _gvol. 20 _gno. 5 _gp. 559-69 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/jep.12184 _zAvailable from publisher's website |
999 |
_c23899571 _d23899571 |